Skip to main content

Table 4 EDSS scores in the control group in each time intervals

From: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Time intervals Paired difference T df Significance
Mean Standard deviation 95% confidence interval
1–12 − 0.58 0.70 − 0.84, − 0.32 − 4.59 29 0.001
2–12 − 0.58 0.70 − 0.84, − 0.32 − 4.59 29 0.001
3–12 − 0.55 0.71 − 0.82, − 0.28 − 4.24 29 0.001
4–12 − 0.47 0.66 − 0.71, − 0.22 − 0.39 29 0.001
5–12 − 0.27 0.57 − 0.48, − .0.05 − 2.57 29 0.016
6–12 − 0.25 0.54 − 0.45, − 0.05 − 2.55 29 0.016
7–12 − 0.23 0.43 − 0.39, − 0.07 − 0.97 29 0.006
8–12 − 0.13 0.41 − 0.29, 0.02 − 1.77 29 0.088
9–12 − 0.03 0.35 − 0.10, 0.16 0.53 29 0.601
10–12 0.05 0.5 − 0.01, 0.11 0.80 29 0.083
11–12 0.02 0.09 − 0.02, 0.05 1.00 29 0.326